{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:46:33Z","timestamp":1789983993987,"version":"4.0.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1038\/s41401-025-01620-9","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T06:08:39Z","timestamp":1753682919000},"page":"86-102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["circSP199a, a circularized RNA sponge targeting miR-199a-5p and -3p, mitigates mouse cardiac hypertrophy and fibrosis"],"prefix":"10.1038","volume":"47","author":[{"given":"Hua-yan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-meng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-hong","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-ting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng-li","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-yan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-yao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-ning","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-dong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-long","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-hong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-xin","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"key":"1620_CR1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41569-018-0044-6","volume":"15","author":"E Bertero","year":"2018","unstructured":"Bertero E, Maack C. Metabolic remodeling in heart failure. Nat Rev Cardiol. 2018;15:457\u201370.","journal-title":"Nat Rev Cardiol"},{"key":"1620_CR2","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1172\/JCI25397","volume":"116","author":"C Perrino","year":"2006","unstructured":"Perrino C, Naga Prasad SV, Mao L, Noma T, Yan Z, Kim HS, et al. Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction. J Clin Invest. 2006;116:1547\u201360.","journal-title":"J Clin Invest"},{"key":"1620_CR3","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/aps.2018.30","volume":"39","author":"SS Zhou","year":"2018","unstructured":"Zhou SS, Jin JP, Wang JQ, Zhang ZG, Freedman JH, Zheng Y, et al. miRNAs in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges. Acta Pharmacol Sin. 2018;39:1073\u201384.","journal-title":"Acta Pharmacol Sin"},{"key":"1620_CR4","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1161\/CIRCULATIONAHA.123.067373","volume":"149","author":"VJ Dzau","year":"2024","unstructured":"Dzau VJ, Hodgkinson CP. RNA therapeutics for the cardiovascular system. Circulation. 2024;149:707\u201316.","journal-title":"Circulation"},{"key":"1620_CR5","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1080\/15476286.2015.1112487","volume":"14","author":"M Xiao","year":"2017","unstructured":"Xiao M, Li J, Li W, Wang Y, Wu F, Xi Y, et al. MicroRNAs activate gene transcription epigenetically as an enhancer trigger. RNA Biol. 2017;14:1326\u201334.","journal-title":"RNA Biol"},{"key":"1620_CR6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.gpb.2017.05.001","volume":"15","author":"Y Liang","year":"2017","unstructured":"Liang Y, Zou Q, Yu W. Steering against wind: a new network of namiRNAs and enhancers. Genomics Proteom Bioinforma. 2017;15:331\u20137.","journal-title":"Genomics Proteom Bioinforma"},{"key":"1620_CR7","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/RES.0000000000000459","volume":"128","author":"J Li","year":"2021","unstructured":"Li J, Salvador AM, Li G, Valkov N, Ziegler O, Yeri A, et al. Mir-30d regulates cardiac remodeling by intracellular and paracrine signaling. Circ Res. 2021;128:e1\u2013e23.","journal-title":"Circ Res"},{"key":"1620_CR8","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7150\/thno.73568","volume":"13","author":"L Gao","year":"2023","unstructured":"Gao L, Qiu F, Cao H, Li H, Dai G, Ma T, et al. Therapeutic delivery of microRNA-125a-5p oligonucleotides improves recovery from myocardial ischemia\/reperfusion injury in mice and swine. Theranostics. 2023;13:685\u2013703.","journal-title":"Theranostics"},{"key":"1620_CR9","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1161\/CIRCULATIONAHA.120.050682","volume":"143","author":"D Ramanujam","year":"2021","unstructured":"Ramanujam D, Sch\u00f6n AP, Beck C, Vaccarello P, Felician G, Dueck A, et al. MicroRNA-21-dependent macrophage-to-fibroblast signaling determines the cardiac response to pressure overload. Circulation. 2021;143:1513\u201325.","journal-title":"Circulation"},{"key":"1620_CR10","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1093\/cvr\/cvab248","volume":"118","author":"G Li","year":"2022","unstructured":"Li G, Shao Y, Guo HC, Zhi Y, Qiao B, Ma K, et al. MicroRNA-27b-3p down-regulates FGF1 and aggravates pathological cardiac remodelling. Cardiovasc Res. 2022;118:2139\u201351.","journal-title":"Cardiovasc Res"},{"key":"1620_CR11","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/cvr\/cvad184","volume":"120","author":"X Liu","year":"2024","unstructured":"Liu X, Li H, Hastings MH, Xiao C, Damilano F, Platt C, et al. miR-222 inhibits pathological cardiac hypertrophy and heart failure. Cardiovasc Res. 2024;120:262\u201372.","journal-title":"Cardiovasc Res"},{"key":"1620_CR12","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.omtn.2021.10.013","volume":"26","author":"N Zeng","year":"2021","unstructured":"Zeng N, Huang YQ, Yan YM, Hu ZQ, Zhang Z, Feng JX, et al. Diverging targets mediate the pathological role of miR-199a-5p and miR-199a-3p by promoting cardiac hypertrophy and fibrosis. Mol Ther Nucleic Acids. 2021;26:1035\u201350.","journal-title":"Mol Ther Nucleic Acids"},{"key":"1620_CR13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nbt.2890","volume":"32","author":"WR Jeck","year":"2014","unstructured":"Jeck WR, Sharpless NE. Detecting and characterizing circular RNAs. Nat Biotechnol. 2014;32:453\u201361.","journal-title":"Nat Biotechnol"},{"key":"1620_CR14","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.omtn.2020.06.022","volume":"21","author":"C Zhang","year":"2020","unstructured":"Zhang C, Huo ST, Wu Z, Chen L, Wen C, Chen H, et al. Rapid development of targeting circRNAs in cardiovascular diseases. Mol Ther Nucleic Acids. 2020;21:568\u201376.","journal-title":"Mol Ther Nucleic Acids"},{"key":"1620_CR15","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.omtn.2018.09.010","volume":"13","author":"X Liu","year":"2018","unstructured":"Liu X, Abraham JM, Cheng Y, Wang Z, Wang Z, Zhang G, et al. Synthetic circular RNA functions as a miR-21 sponge to suppress gastric carcinoma cell proliferation. Mol Ther Nucleic Acids. 2018;13:312\u201321.","journal-title":"Mol Ther Nucleic Acids"},{"key":"1620_CR16","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1038\/s41374-019-0273-2","volume":"99","author":"Z Wang","year":"2019","unstructured":"Wang Z, Ma K, Cheng Y, Abraham JM, Liu X, Ke X, et al. Synthetic circular multi-miR sponge simultaneously inhibits miR-21 and miR-93 in esophageal carcinoma. Lab Invest. 2019;99:1442\u201353.","journal-title":"Lab Invest"},{"key":"1620_CR17","first-page":"1032","volume":"15","author":"I Jost","year":"2018","unstructured":"Jost I, Shalamova LA, Gerresheim GK, Niepmann M, Bindereif A, Rossbach O. Functional sequestration of microRNA-122 from Hepatitis C Virus by circular RNA sponges. RNA Biol. 2018;15:1032\u20139.","journal-title":"RNA Biol"},{"key":"1620_CR18","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.ymthe.2020.04.006","volume":"28","author":"A Lavenniah","year":"2020","unstructured":"Lavenniah A, Luu TDA, Li YP, Lim TB, Jiang J, Ackers-Johnson M, et al. Engineered circular RNA sponges act as miRNA inhibitors to attenuate pressure overload-induced cardiac hypertrophy. Mol Ther. 2020;28:1506\u201317.","journal-title":"Mol Ther"},{"key":"1620_CR19","volume":"6","author":"CM Tang","year":"2016","unstructured":"Tang CM, Liu FZ, Zhu JN, Fu YH, Lin QX, Deng CY, et al. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy. Sci Rep. 2016;6:36146.","journal-title":"Sci Rep"},{"key":"1620_CR20","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1016\/j.bbadis.2019.06.004","volume":"1865","author":"JN Liang","year":"2019","unstructured":"Liang JN, Zou X, Fang XH, Xu JD, Xiao Z, Zhu JN, et al. The Smad3-miR-29b\/miR-29c axis mediates the protective effect of macrophage migration inhibitory factor against cardiac fibrosis. Biochim Biophys Acta Mol Basis Dis. 2019;1865:2441\u201350.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"1620_CR21","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/cvr\/cvz215","volume":"116","author":"H Li","year":"2020","unstructured":"Li H, Xu JD, Fang XH, Zhu JN, Yang J, Pan R, et al. Circular RNA circRNA_000203 aggravates cardiac hypertrophy via suppressing miR-26b-5p and miR-140-3p binding to Gata4. Cardiovasc Res. 2020;116:1323\u201334.","journal-title":"Cardiovasc Res"},{"key":"1620_CR22","volume":"12","author":"YR Lewis-Israeli","year":"2021","unstructured":"Lewis-Israeli YR, Wasserman AH, Gabalski MA, Volmert BD, Ming Y, Ball KA, et al. Self-assembling human heart organoids for the modeling of cardiac development and congenital heart disease. Nat Commun. 2021;12:5142.","journal-title":"Nat Commun"},{"key":"1620_CR23","volume":"57","author":"J Yang","year":"2024","unstructured":"Yang J, Lei W, Xiao Y, Tan S, Yang J, Lin Y, et al. Generation of human vascularized and chambered cardiac organoids for cardiac disease modelling and drug evaluation. Cell Prolif. 2024;57:e13631.","journal-title":"Cell Prolif"},{"key":"1620_CR24","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/jcmm.12445","volume":"19","author":"S Huang","year":"2015","unstructured":"Huang S, Zou X, Zhu JN, Fu YH, Lin QX, Liang YY, et al. Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy. J Cell Mol Med. 2015;19:608\u201319.","journal-title":"J Cell Mol Med"},{"key":"1620_CR25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/21541264.2015.1071301","volume":"6","author":"C Huang","year":"2015","unstructured":"Huang C, Shan G. What happens at or after transcription: Insights into circRNA biogenesis and function. Transcription. 2015;6:61\u201364.","journal-title":"Transcription"},{"key":"1620_CR26","doi-asserted-by":"crossref","first-page":"877","DOI":"10.7150\/jca.11735","volume":"6","author":"Z Ye","year":"2015","unstructured":"Ye Z, Jin H, Qian Q. Argonaute 2: a novel rising star in cancer research. J Cancer. 2015;6:877\u201382.","journal-title":"J Cancer"},{"key":"1620_CR27","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3389\/fphys.2018.00382","volume":"9","author":"VFM Segers","year":"2018","unstructured":"Segers VFM, Brutsaert DL, De Keulenaer GW. Cardiac remodeling: endothelial cells have more to say than just NO. Front Physiol. 2018;9:382.","journal-title":"Front Physiol"},{"key":"1620_CR28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fcvm.2018.00101","volume":"5","author":"V Talman","year":"2018","unstructured":"Talman V, Kivel\u00e4 R. Cardiomyocyte-endothelial cell interactions in cardiac remodeling and regeneration. Front Cardiovasc Med. 2018;5:101.","journal-title":"Front Cardiovasc Med"},{"key":"1620_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-0716-2823-2_1","volume":"2595","author":"A Vishnoi","year":"2023","unstructured":"Vishnoi A, Rani S. miRNA biogenesis and regulation of diseases: an updated overview. Methods Mol Biol. 2023;2595:1\u201312.","journal-title":"Methods Mol Biol"},{"key":"1620_CR30","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1126\/science.319.5871.1782","volume":"319","author":"J Couzin","year":"2008","unstructured":"Couzin J. MicroRNAs make big impression in disease after disease. Science. 2008;319:1782\u20134.","journal-title":"Science"},{"key":"1620_CR31","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.tig.2022.02.006","volume":"38","author":"C Diener","year":"2022","unstructured":"Diener C, Keller A, Meese E. Emerging concepts of miRNA therapeutics: from cells to clinic. Trends Genet. 2022;38:613\u201326.","journal-title":"Trends Genet"},{"key":"1620_CR32","doi-asserted-by":"crossref","first-page":"7167","DOI":"10.3390\/ijms23137167","volume":"23","author":"PTB Ho","year":"2022","unstructured":"Ho PTB, Clark IM, Le LTT. MicroRNA-based diagnosis and therapy. Int J Mol Sci. 2022;23:7167.","journal-title":"Int J Mol Sci"},{"key":"1620_CR33","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.3390\/ijms25031469","volume":"25","author":"AA Seyhan","year":"2024","unstructured":"Seyhan AA. Trials and tribulations of microRNA therapeutics. Int J Mol Sci. 2024;25:1469.","journal-title":"Int J Mol Sci"},{"key":"1620_CR34","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1261\/rna.2414110","volume":"16","author":"MS Ebert","year":"2010","unstructured":"Ebert MS, Sharp PA. MicroRNA sponges: progress and possibilities. RNA. 2010;16:2043\u201350.","journal-title":"RNA"},{"key":"1620_CR35","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nmeth1079","volume":"4","author":"MS Ebert","year":"2007","unstructured":"Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods. 2007;4:721\u20136.","journal-title":"Nat Methods"},{"key":"1620_CR36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cca.2019.09.013","volume":"500","author":"D Li","year":"2020","unstructured":"Li D, Zhang J, Li J. Role of miRNA sponges in hepatocellular carcinoma. Clin Chim Acta. 2020;500:10\u201319.","journal-title":"Clin Chim Acta"},{"key":"1620_CR37","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.05005","volume":"4","author":"V Agarwal","year":"2015","unstructured":"Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015;4:e05005.","journal-title":"Elife"},{"key":"1620_CR38","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1007\/s11010-021-04100-w","volume":"476","author":"KH Lin","year":"2021","unstructured":"Lin KH, Kumar VB, Shanmugam T, Shibu MA, Chen RJ, Kuo CH, et al. miR-145-5p targets paxillin to attenuate angiotensin II-induced pathological cardiac hypertrophy via downregulation of Rac1, pJNK, p-c-Jun, NFATc3, ANP and by Sirt-1 upregulation. Mol Cell Biochem. 2021;476:3253\u201360.","journal-title":"Mol Cell Biochem"},{"key":"1620_CR39","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.bj.2021.11.012","volume":"45","author":"W Zhou","year":"2022","unstructured":"Zhou W, Ji L, Liu X, Tu D, Shi N, Yangqu W, et al. AIFM1, negatively regulated by miR-145-5p, aggravates hypoxia-induced cardiomyocyte injury. Biomed J. 2022;45:870\u201382.","journal-title":"Biomed J"},{"key":"1620_CR40","volume":"74","author":"Q Zhou","year":"2021","unstructured":"Zhou Q, Deng J, Yao J, Song J, Meng D, Zhu Y, et al. Exercise downregulates HIPK2 and HIPK2 inhibition protects against myocardial infarction. EBioMedicine. 2021;74:103713.","journal-title":"EBioMedicine"},{"key":"1620_CR41","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.tcm.2012.07.003","volume":"22","author":"C Riehle","year":"2012","unstructured":"Riehle C, Abel ED. PGC-1 proteins and heart failure. Trends Cardiovasc Med. 2012;22:98\u2013105.","journal-title":"Trends Cardiovasc Med"},{"key":"1620_CR42","volume":"14","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zhao R, Wu C, Liang X, He L, Wang L, et al. Activation of the sirtuin silent information regulator 1 pathway inhibits pathological myocardial remodeling. Front Pharmacol. 2023;14:1111320.","journal-title":"Front Pharmacol"},{"key":"1620_CR43","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2022.102207","volume":"64","author":"C Humeres","year":"2022","unstructured":"Humeres C, Venugopal H, Frangogiannis NG. Smad-dependent pathways in the infarcted and failing heart. Curr Opin Pharmacol. 2022;64:102207.","journal-title":"Curr Opin Pharmacol"},{"key":"1620_CR44","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1007\/s12015-022-10385-1","volume":"18","author":"L Zhu","year":"2022","unstructured":"Zhu L, Liu K, Feng Q, Liao Y. Cardiac organoids: a 3D technology for modeling heart development and disease. Stem Cell Rev Rep. 2022;18:2593\u2013605.","journal-title":"Stem Cell Rev Rep"},{"key":"1620_CR45","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.7150\/thno.67661","volume":"12","author":"J Cho","year":"2022","unstructured":"Cho J, Lee H, Rah W, Chang HJ, Yoon YS. From engineered heart tissue to cardiac organoid. Theranostics. 2022;12:2758\u201372.","journal-title":"Theranostics"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01620-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01620-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01620-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T07:22:28Z","timestamp":1767424948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01620-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1620"],"URL":"https:\/\/doi.org\/10.1038\/s41401-025-01620-9","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"assertion":[{"value":"27 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}